Four bills cleared by the House E & C Committee Thursday would address ways to overcome barriers to faster approval by FDA and reimbursement by the Centers for Medicare and Medicaid Services for device alternatives to opioids to control pain and treat addictions.
The device industry has taken note that medtech products to treat pain and help manage opioid addictions have not received...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?